3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Dermatologic
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Melanoma
1
Interventions
pembrolizumab
380
Carboplatin
279
Specimen Handling
266
Nivolumab
257
Magnetic Resonance Spectroscopy
247
Cyclophosphamide
242
Cisplatin
217
Paclitaxel
207
Radiotherapy
196
Biopsy
171
Gemcitabine
158
Dexamethasone
149
durvalumab
147
atezolizumab
128
Rituximab
123
Doxorubicin
117
Bevacizumab
115
Ipilimumab
114
Lenalidomide
113
Radiation
111
Pemetrexed
104
Docetaxel
104
Etoposide
102
fludarabine
97
venetoclax
96
Capecitabine
94
Radiosurgery
93
Fluorouracil
93
Oxaliplatin
91
Prednisone
90
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Tumor Necrosis Factor-alpha
×
1 year
×
Clear all
NCT05222932
2025-08-07
AVENTIL
TILT Biotherapeutics Ltd.
Phase 1
Active not recruiting
15 enrolled